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SUMMARY  
Chronic infections promote the terminal differentiation (or exhaustion) of T-cells and are thought 
to preclude the formation of memory T-cells. Contrasting the latter, we discovered a small 
subpopulation of virus-specific CD8 T-cells that sustains the T-cell response in chronic infections. 
These cells are defined by - and depend on - the expression of the transcription factor Tcf1 (T cell 
factor 1) and show key characteristics of central memory cells while lacking an effector signature. 
Unlike conventional memory cells, Tcf1+ T-cells display hallmarks of an “exhausted” phenotype, 
including the expression of certain inhibitory receptors, and these cells are critical for the cellular 
expansion in response to inhibitory receptor blockade. These findings identify a memory-like T-
cell population as a prime target for therapeutic interventions to improve the immune response in 
chronic infections. 
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INTRODUCTION 
The recognition of pathogen-derived antigens triggers a massive expansion of rare antigen-
specific CD8+ T-cells. Their progeny usually accumulate in large numbers of armed effector 
T-cells and these normally contribute to the eradication of viral pathogens (Williams and Bevan, 
2007). In contrast, the immune system and specifically CD8+ T-cells typically fail to eliminate the 
human immunodeficiency virus [HIV], the hepatitis C virus [HCV], or certain strains of the 
Lymphocytic choriomeningitis virus [LCMV] in mice. Nonetheless, such chronic infections go 
along with strong T-cell responses but compared to acutely resolved infections, T-cells in 
persisting infections typically show strong impairments in cytokine production (IFNg, TNF and IL-
2) and express high levels of inhibitory receptors such as PD-1 (programmed cell death-1) and 
Lymphocyte-activation gene 3 (Lag-3) (Klenerman and Hill, 2005; Kuchroo et al., 2014; Speiser 
et al., 2014; Virgin et al., 2009; Wherry, 2011; Wherry et al., 2007). These phenotypic changes 
along with the failure of the immune system to clear the pathogens lead to the concept that 
persisting infection exhaust a functional T-cell response, promote primarily terminally 
differentiated T-cells, and preclude the formation of CD8+ T-cell memory (Mueller and Ahmed, 
2009; Shin et al., 2007; Wherry et al., 2004; Williams and Bevan, 2007). Notwithstanding, these 
terminally differentiated effector cells persist in large numbers for extended periods of time and 
they still mediate a certain level of virus control. The latter is supported by the frequent 
emergence of T-cell epitope-escape variants in HIV infections (Price et al., 2004; Walker and 
McMichael, 2012) and observations that the depletion of CD8+ T-cells from Rhesus macaques 
chronically infected with SIV severely increases virus titers (Jin et al., 1999; Schmitz et al., 1999). 
Moreover, anti-viral activity and the CD8+ T cell response significantly improve when the signaling 
via inhibitory receptors such as PD-1 is prevented (Barber et al., 2006). All these observations 
indicate that the immune response has not irreversibly ceased. However, the molecular 
mechanisms that maintain the terminally differentiated T cells in chronic infections and that 
improve the T-cell response following check-point inhibition remain poorly understood.  
While classical memory was so far not thought to form in chronic infections (Mueller and Ahmed, 
2009; Shin et al., 2007; Wherry et al., 2004; Williams and Bevan, 2007), antigen-specific T-cell 
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populations were recently shown to undergo significant expansion following transfer into naïve 
host mice (Utzschneider et al., 2013). Based on all the aforementioned evidence we 
hypothesized that the prolonged presence of pathogen-specific CD8+ T-cells in chronic viral 
infections depends on their generation from T-cells with strong expansion capacity and possible 
memory features (Speiser et al., 2014). The transcription factor Tcf1 (T-cell factor-1, encoded by 
the Tcf7 gene) has a critical role in maintaining protective immunity after resolution of acute 
infections (Jeannet et al., 2010; Zhou et al., 2010). We thus postulated that a putative memory 
function in chronic infections might depend on Tcf1.  
With the help of a newly generated Tcf1 reporter mouse strain and Tcf1 knockout mice we 
identify an antigen-specific CD8+ T cell subpopulation, which is essential for sustaining the T-cell 
response in chronic infections and for the re-expansion of antigen-specific T-cells following 
inhibitory receptor blockade. This subpopulation displays a unique differentiation state. While it 
lacks an effector cell signature it displays multiple characteristics of central memory T-cells 
including regeneration capacity and the ability to produce differentiated effector T-cells. In 
contrast to conventional memory cells, Tcf1+ CD8 T-cells also display the hallmarks of an 
“exhausted” phenotype including the expression of certain inhibitory receptors. Inhibitory receptor 
blockade expands this memory-like T cell population. Thus, we demonstrate a central role of 
memory-like cells for maintaining T-cell responses in chronic infections and for therapeutic 
interventions.  
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RESULTS 
Normal expansion but impaired CD8 T-cell maintenance and virus control in the absence 
of Tcf1 
The continuous presence of differentiated cells within a tissue can be explained by cellular 
longevity (Spalding et al., 2005), the replication and self-renewal of differentiated cells (Dor et al., 
2004) or their de novo generation from a pool of undifferentiated precursor cells (Barker et al., 
2007). We hypothesized that the prolonged presence of pathogen-specific CD8+ T-cells in 
chronic viral infections depends on their generation from T-cells with memory function. The 
transcription factor Tcf1 (Tcf7) has a critical role in maintaining protective immunity after 
resolution of acute infections (Jeannet et al., 2010; Zhou et al., 2010). We therefore postulated 
that a putative memory function in chronic infections depends on Tcf1. To test this, Tcf7-/- [KO] or 
wild type [Wt] mice were inoculated with the LCMV clone-13 [c13] strain, which establishes a 
chronic infection. The two strains had similar frequencies of CD8+ T-cells specific for the LCMV-
derived gp33 and gp276 epitopes on day 8 (d8) post-infection (Figure 1A) but 8 weeks later KO 
mice had reduced frequencies of epitope-specific T-cells (Figure 1B). In agreement with these 
observations, both mouse strains showed initially similar virus titers in the kidneys and the blood 
(Figure 1C, E), but KO mice failed to control LCMV c13 infection (Figure 1D, E). Thus, Tcf1 
expression is dispensable for the initial T-cell expansion but essential for the long-term 
maintenance of the T-cell response and pathogen control. 
To determine whether the defect in maintaining KO T-cells was CD8+ T-cell intrinsic, we 
transferred small numbers of Wt or KO CD8+ T-cells expressing a gp33-specific transgenic TCR 
[P14 T-cells] into CD45 congenic C57BL/6 [B6] hosts. While Wt and KO P14 T-cells had 
accumulated in similar numbers 8 days after LCMV c13 infection (Figure 1F), tenfold fewer KO 
than Wt P14 T-cells were detected at d28 (Figure 1G). A similar difference was observed using 
Vb5 transgenic host mice (Figure 1H, S1C), which show a reduced endogenous T-cell response 
to LCMV and, similar to CD4-depleted B6 mice, higher c13 titers than B6 (Utzschneider et al., 
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2013). Of note, virus titers were comparably high in Vb5 hosts with Wt or KO P14 cells (data not 
shown), indicating that Wt and KO P14 cells are in similar infectious and inflammatory 
environments. The reduced persistence of KO P14 cells was also not due to their elimination by 
the host. Indeed, chronically infected Vb5 hosts with residual KO P14 cells did not reject freshly 
transferred KO P14 cells (Figure S1). Altogether, we conclude that the absence of Tcf1 impairs 
the long-term maintenance of the CD8 T-cell response in chronic infections in a cell intrinsic 
fashion.  
 
T-cell differentiation remains unaltered in the absence of Tcf1  
As the long-term maintenance of KO P14 T-cells was reduced we next addressed whether this 
was associated with altered T-cell differentiation. On d8 post infection, KO and Wt P14 T-cells 
displayed similarly reduced abilities to co-produce TNF and IFNg and comparably increased 
expression of PD-1 and Lag-3 (Figure S2). At the chronic phase of c13 infection (d28), the 
phenotypic and functional analysis of KO P14 T-cells was hampered by their low abundance. 
This prompted us to use Vb5 recipient mice, which tolerate ten-fold higher P14 cell input without 
lethal immunopathology or virus elimination. These recipients harbor more P14 cells during 
chronic infection yet the difference between Wt and KO P14 cells is maintained (Figure 1H). Four 
weeks post infection, KO and Wt P14 T-cells displayed comparably high expression of PD-1, 
Lag-3 and GzmB (Figure 2A-C), and a similarly reduced ability to co-produce TNF and IFNg  
(Figure 2D). The only difference was a minor reduction in the fraction of KO P14 T-cells 
producing IFNg  (Figure 2E). Thus, the initial expansion, effector differentiation and exhaustion 
remain unaltered while T-cell maintenance is severely compromised without Tcf1.   
 
Tcf1 expression preserves the proliferative potential of T cells in chronic infection 
We next investigated whether the impaired maintenance of KO T-cells stemmed from a 
decreased proliferative capacity. We tested this by transferring Wt and KO P14 cells obtained 
from chronic c13 infection into secondary recipients followed by LCMV Armstrong [Arm] 
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inoculation, which causes an acute infection (Figure 3A). Wt P14 T-cells underwent robust 
expansion in this setup (Figure 3B), consistent with a prior report (Utzschneider et al., 2013). In 
contrast, KO P14 T-cells essentially failed to re-expand (Figure 3B).  
Since re-expansion potential of chronically stimulated CD8+ T cells depends on Tcf1, we next 
characterized Tcf1 expression by virus-specific Wt P14 T-cells in LCMV c13 infections. Tcf1 is 
expressed by all naive T-cells, a minor fraction of effector cells but by most memory T-cells found 
after a resolved acute LCMV infection (Boudousquie et al., 2014) (Figure 3C). In contrast, Tcf1 
was expressed by a stable fraction of around 10% of Wt P14 T-cells throughout c13 infection in 
B6 recipients (Figure 3C) and in Vb5 hosts (Figure S3) where viral titers are significantly higher. 
Together with the absence of re-expansion capacity of KO P14 cells, this strongly suggested that 
the proliferative capacity of wild type T-cells was confined to this Tcf1+ subpopulation.  
 
Tcf1 expressing T-cells maintain the immune response to chronic infection  
To confirm the above observations in polyclonal T cells and to formally address whether the 
expansion capacity of Wt T-cells from chronic infections resides in the Tcf1+ sub-population, we 
generated a Tcf1 reporter mouse strain. A bacterial artificial chromosome (BAC) containing the 
Tcf7 locus was modified by the insertion of GFP (green fluorescent protein) into the translation 
start site present in exon 1 of Tcf7 (Figure S4A). The modified BAC was used to generate 
transgenic mice. 
We first ensured that GFP expression in reporter mice corresponded to that of Tcf1 protein. In 
agreement with intracellular Tcf1 staining, most CD8+ T-cells expressed high levels of GFP (not 
shown). While B cells were negative for Tcf1 and for GFP, P14 T-cells from naive reporter mice 
were all GFP+, which corresponded to Tcf1 protein expression (Figure 4A). We next verified the 
regulation of the Tcf1 reporter during chronic infection, as schematically shown in Figure 4B. 
Similar to Tcf1 protein expression, only around 10% of P14 reporter cells were GFP+ at d28 of 
chronic infection (Figure 4C, left). Flow sorted GFP+ P14 reporter cells were intracellular Tcf1+, 
while Tcf1 was not detectable in sorted GFP- P14 cells (Figure 4C, right), validating the reporter 
to track Tcf1-expressing CD8+ T-cells during chronic infection.  
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We first used the reporter to investigate Tcf1 expression by polyclonal CD8 T cells specific for 
distinct LCMV epitopes. Very similar to Wt P14 cells, Tcf1-GFP was expressed by sub-
populations of 6-10% of polyclonal CD8 T-cells specific for distinct LCMV epitopes (gp276, gp33 
and np396) at d29 of c13 infection (Figure S4B). Thus, although np396 and gp276 tetramer+ 
cells differ in their degree of “exhaustion” (Wherry et al., 2003), they contain similar 
subpopulations of Tcf1+ cells. Notwithstanding, the epitope specificity of the cells impacts the 
absolute number of Tcf1+ tetramer+ cells. 
Next we investigated the proliferative potential of polyclonal Wt Tcf1+ and Tcf1- CD8+ T-cells. 
Total CD8+ spleen cells from chronically infected B6 reporter mice were separated into Tcf1-GFP+ 
and Tcf1-GFP- populations and transferred into Vb5 hosts prior to LCMV Arm infection (Figure 
S4C). Eight days later, we observed a massive expansion of transferred Tcf1+ CD8 T-cells 
specific for gp276, gp33 and np396. In comparison, the transferred Tcf1- CD8 T-cells essentially 
failed to re-expand (Figure S4D, E). This showed that the re-expansion capacity of polyclonal 
CD8 T cells is confined to the Tcf1+ sub-population. To compare the re-expansion potential of 
Tcf1+ and Tcf1- T-cells that have an identical TCR we used monoclonal P14 reporter mice as 
schematically shown in Figure 4B. Tcf1-GFP+ P14 T-cells isolated from chronically infected Vb5 
animals underwent robust expansion in LCMV Arm-infected secondary Vb5 recipients, while the 
Tcf1-GFP- P14 population essentially failed to re-expand at day 8 post infection (Figure 4D). The 
increased re-expansion capacity of Tcf1+ cells correlated with an improved control of viral 
infection. While only occasional Vb5 recipients that received no cells or Tcf1-GFP- P14 cells, had 
controlled LCMV Arm infection at d8 (1 of 11 mice; (9%) and 1/13 (8%), respectively), transfer of 
Tcf1-GFP+ P14 cells led to viral control in spleen or blood in a considerable fraction of Vb5 
recipients  (5 /13 (38%)). A corresponding effect was observed using polyclonal CD8 T cells 
(Figure S4F), indicating that Tcf1+ cells have enhanced protective potential. 
Interestingly, following re-challenge with LCMV Arm, descendants of P14 Tcf1-GFP+ cells were 
mostly (90%) GFP-, but a subpopulation of cells (~10%) was again GFP+ (Figure 4E). Based on 
cell numbers, even Tcf1-GFP+ cells had robustly expanded as compared to input (Figure 4F). On 
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the other hand P14 cells derived from transferred Tcf1-GFP- cells remained GFP- (Figure 4E). 
Corresponding data were obtained for polyclonal CD8 T-cell populations specific for gp276 and 
gp33 (Figure S4G, H and not shown). Thus, re-challenge of Tcf1+ cells not only leads to the 
production of considerable numbers of more differentiated progeny but leads also to the 
expansion and thus the re-generation of Tcf1+ cells.  
We further tested if Tcf1-expressing cells are sufficient to sustain the immune response to chronic 
infection (Figure 4G). Tcf1-GFP- P14 T-cells, isolated from chronically infected recipients 
remained essentially undetectable following transfer into c13 infection-time-matched recipients. In 
contrast, cells derived from the Tcf1-GFP+ population gradually increased over time (Figure 4H, 
I), which is remarkable since 10 times fewer Tcf1-GFP+ than Tcf1-GFP- cells had been 
transferred. Again, the cells derived from transferred Tcf1-GFP+ P14 T-cells were mainly GFP- 
cells but GFP+ cells were also present (data not shown). We conclude that the T-cell response to 
chronic infection has a hierarchical structure whereby T cells expressing Tcf1 are necessary and 
sufficient to sustain the response.  
 
Tcf1+ cells from chronic infections have characteristics of memory and exhausted but not 
of effector T-cells. 
To molecularly characterize Tcf1+ CD8 T-cells we performed RNAseq analysis of Tcf1-GFP+ P14 
cells (chronic Tcf1+) and Tcf1-GFP- P14 cells (chronic Tcf1-) at d28 of LCMV c13 infection. The 
gene expression analysis further included naive P14 cells (naive) as well as Tcf1-GFP+ and Tcf1-
GFP- P14 cells at d28 of acute resolved LCMV Arm infection (Tcf1+ memory and Tcf1- memory).  
Principal component analysis applied to normalized RNA-seq gene read counts revealed that 
naïve cells, memory cells, chronic Tcf1- and chronic Tcf1+ cells are distinct, while Tcf1+ and Tcf1- 
memory cells are more closely related (Figure 5A). We further compared these data with 
available microarray data from effector, exhausted and memory CD8 T-cells obtained from LCMV 
Arm or c13 infected mice (Doering et al., 2012). As expected, this revealed similarity of all 
memory populations and of exhausted cells with chronic Tcf1- cells. The latter similarity is 
explained by the fact that 90% of P14 cells in chronic infection are Tcf1-. These data validate the 
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combined analysis of the two datasets. Finally the data showed that effector cells are 
considerably more related to chronic Tcf1- than to chronic Tcf1+ cells (Figure 5B). In agreement 
with these analyses, >2000 genes were differentially expressed in pairwise comparisons with 
naïve cells (False discovery rate (FDR) 5%) (Figure S5A) and unique sets of genes defined 
chronic Tcf1- cells (n=502) and chronic Tcf1+ CD8 T-cells (n=498) (FDR 5%, Fold Change 
(FC)>2) (Figure S5B, Table S1). Collectively, these data suggest that Tcf1+ cells from chronic 
infections display a unique transcriptional profile. 
We directly compared the gene expression profiles of chronic Tcf1+ and Tcf1- cells (Table S2), 
which reside in the same host. Genes down-regulated in chronic Tcf1+ cells were highly 
associated with the GO and KEGG pathway term  “cell cycle” (p=6.23e-33 and p=8.08e-11, 
respectively) (Table S3). Consistent with these findings, the expression of selected cell-division-
related genes (Mki67, Ccnb1, Plk1, Aurkb) was low in chronic Tcf1+ relative to chronic Tcf1- cells 
(Fig. S6A), indicating that the Tcf1+ population is relatively quiescent yet harbors the capacity to 
mediate population expansion upon re-challenge.  
We next determined whether chronic Tcf1+ CD8 T-cells display hallmarks of memory cells, 
effector cells and/or exhausted CD8 T-cells. Gene set enrichment tests did not provide evidence 
for a significant enrichment of a memory signature (Doering et al., 2012) (generated relative to 
naive cells) in chronic Tcf1+ cells (Figure S5C), which may be due to the fact that many memory 
genes are expressed in naive cells. Indeed, multiple genes required for the formation of CD8 T 
cell memory were expressed at higher levels in chronic Tcf1+ as compared to Tcf1- P14 cells (IL7r, 
Sell (encoding CD62L), Ccr7, Id3, Bcl6) (Figure S6B), whereby certain genes were expressed at 
higher levels in chronic Tcf1+ CD8 T-cells as compared to Tcf1+ memory cells or naive cells (Id3, 
Bcl6). Specific memory features were verified at the level of protein expression and extended 
using functional analyses. We detected significant CD62L and IL7Ra (CD127) expression 
selectively by Tcf1+ cells, both by P14 and polyclonal CD8 T-cells (Figure 5C, S6C). The ability 
to receive IL-7 signals may explain in part the maintenance of Tcf1+ cells (Kaech et al., 2003). 
Further, a subpopulation of Tcf1+ P14 cells expressed IL-2 (Figure 5D). Moreover, Tcf1+ cells 
expressed Eomes and low levels of T-bet (Tbx21)(Figure 5E, S6B, S6D), similar to conventional 
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memory cells (Joshi et al., 2007). The low levels of T-bet in the Tcf1+ precursor population was 
unexpected given that T-betlow cells in chronic infections are reportedly terminally differentiated 
(Paley et al., 2012). However, Tcf1 is expressed by a relatively small subset of T-betlow cells 
indicating that heterogeneity of the T-betlow population may explain the apparent discrepancy. We 
conclude that Tcf1+ CD8+ T-cells in chronic infection exhibit striking similarities with central 
memory CD8+ T-cells.  
Conversely, gene set enrichment tests revealed a significant overlap of an effector gene 
signature (Doering et al., 2012) with chronic Tcf1- versus chronic Tcf1+ cells (Figure 5F), 
indicating that chronic Tcf1+ cells lack effector cell features. Indeed, selected genes associated 
with effector CD8 T cell differentiation or function were expressed at low levels in chronic Tcf1+ as 
compared to Tcf1- T-cells (Klrg1, Cx3cr1, Gzma, Gzmb, Prf1, Tbx21, Id2, Prdm1) (Figure S6D). 
Remarkably, the expression of these effector genes was even lower in chronic Tcf1+ T-cells as 
compared to conventional memory cells, but not as low as in naive T-cells. Flow cytometry 
analysis confirmed the absence of GzmB and KLRG1 in Tcf1+ but presence in chronic Tcf1- cells 
(Figure 5G, S6E). Thus, Tcf1+ cells generally lack the hallmarks of effector CD8 T cells. 
We next addressed whether Tcf1+ T-cells displayed hallmarks of exhausted T-cells or whether 
this phenotype was acquired during the expansion and differentiation of Tcf1+ to Tcf1- cells. 
Interestingly, an exhaustion gene signature (Doering et al., 2012) was not enriched in chronic 
Tcf1- cells relative to chronic Tcf1+ (Figure S5D). As chronic Tcf1- cells are very similar to 
exhausted cells (see e.g. the PCA) we conclude that chronic Tcf1- and Tcf1+ cells predominantly 
share an exhaustion gene signature. In agreement with these data, specific exhaustion 
associated genes were expressed comparably by chronic Tcf1+ and Tcf1- cells (Pdcd1, Lag3, c-
Maf) (Figure S6F), which was confirmed by flow cytometry for PD-1 and Lag-3 both in P14 and in 
polyclonal T cells (Figure 5H, S6G). Thus Tcf1+ T-cells displayed multiple hallmarks of exhausted 
T-cells. Further, the gene set enrichment tests indicated that small fractions of exhaustion genes 
are preferentially expressed by either Tcf1+ or Tcf1- cells (Figure S5D). Indeed, specific 
exhaustion genes were expressed at low levels in Tcf1+ T-cells (Cd244, Havcr2 (Tim3), Ccl3) 
while Ctla4 was expressed at higher levels Tcf1+ as compared to Tcf1- T-cells (Figure S6F). 
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Functionally, Tcf1+ T-cells produced slightly more IFNg than Tcf1- cells, but slightly fewer of the 
IFNg+ cells co-produced TNF (Figure 5I). This feature may reflect the relative absence of effector 
differentiation of Tcf1+ cells, rather than exhaustion. Thus, Tcf1+ CD8+ T-cells in chronic infections 
show a unique differentiation state, with a relative absence of effector differentiation but 
characteristics of memory CD8+ T-cells together an exhausted phenotype.  
 
The presence of Tcf1+ T cells in chronic infection requires Tcf1 expression 
We next sought to address whether Tcf1 expression was of relevance for the presence and/or the 
function of the Tcf1+ T cell population. To this end, we generated P14 Tcf1-GFP reporter mice 
that do not express Tcf1 protein (KO reporter). P14 KO reporter cells isolated from naive mice 
retained high GFP expression (Figure 5K), indicating that the activity of the Tcf7 locus does not 
depend on the Tcf1 protein and that the KO reporter could be used to follow “Tcf1+ T cells lacking 
Tcf1 protein”. As expected, Wt P14 reporter cells responding to c13 infection contained a 
sizeable population of Tcf1-GFP+ cells. In contrast, when using KO reporter cells, the fraction and 
the number of Tcf1-GFP+ cells were strongly reduced at d8 and d28 of c13 infection (Figure 5L). 
To independently confirm the absence of Tcf1-GFP+ cells, we exploited the gene expression 
analysis and identified Slamf6 (Ly108) as a specific marker of Wt Tcf1-GFP+ P14 cells (Figure 
5M). High-level Slamf6 (Ly108) expression defined >6% of total Wt P14 cells but only around 1% 
of KO P14 cells (Figure 5M). We conclude that Tcf1+ Slamf6hi CD8 T-cells in chronic infections 
depend on Tcf1 protein expression. The absence of these Tcf1+ Slamf6hi CD8 T-cells in KO mice 
may account for the impaired maintenance of the T cell response to chronic infections. 
 
Tcf1+ T cell subpopulations exists in chronic human infections  
We next determined if a similar Tcf1+ subpopulation is also detectable among virus-specific CD8+ 
T-cells in patients with chronic HCV infection. We found that 20-60% of HCV-specific CD8+ T-
cells were Tcf1+ (Figure 6A-C). This contrasts with the uniform Tcf1+ phenotype of naive and 
central memory CD8+ T-cells in healthy donors (Figure 6B, C). Very similar to the observations in 
LCMV c13 infection, Tcf1+ HCV-specific cells display higher expression of the memory marker 
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CD127 than Tcf1- cells and they express PD-1 (Figure 6D, E). These data provide evidence for 
the existence of Tcf1+ CD8 T cells in human chronic infection. 
 
The expansion of CD8 T cells in response to PD-1 blockade depends on Tcf1  
Several studies have shown that blocking PD-1/PD-L1 interaction increases effector functions 
and proliferation of antigen specific CD8+ T-cells and this coincides with a decrease in pathogen 
or malignant tumor load (Barber et al., 2006; Herbst et al., 2014; Sakuishi et al., 2010). While PD-
1/PD-L1 blockade increases effector functions and proliferation of antigen specific CD8+ T-cells, 
the exact mechanism underlying the enhanced immune response remains elusive. Based on 
theses findings, we tested if the expansion of CD8+ T-cells upon blockade of the PD-1/PD-L1 
interaction depends on Tcf1 (Figure 7A). In agreement with prior findings (Barber et al., 2006), 
PD-1/PD-L1 blockade in LCMV c13 infected mice increased the Wt P14 T-cell population 
compared to isotype control treated mice. In contrast, KO P14 T-cells failed to expand (Figure 
7B). Thus the expansion of chronically stimulated CD8+ T-cells in response to inhibitory receptor 
blockade depends on Tcf1 expression.  
Importantly, PD-1/PD-L1 blockade resulted in an enlarged Wt Tcf1+ P14 population (Figure 7C). 
We thus addressed whether the expansion of antigen-specific T cells depended on the presence 
of Tcf1+ cells. Indeed Tcf1-GFP+ P14 T-cells from c13 infected primary recipients significantly 
expanded following transfer into infection time matched secondary recipients and treatmed with 
PD-1 mAb (Figure 7D). In contrast, PD-1 mAb had no significant effect on transferred Tcf1-GFP- 
P14 cells (Figure 7E). These data demonstrate that the effectiveness of this therapeutic 
intervention depends on the Tcf1+ CD8 T-cell population.  
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DISCUSSION 
The loss of certain T-cell functions together with the decline in T-cell numbers led originally to the 
hypothesis that persisting infections are concomitant with rapid deterioration of the T-cell 
response without the formation of memory T-cells. Here, we establish that long-term T-cell 
responses in chronic infections are maintained by a subpopulation of memory-like cells 
expressing Tcf1. While memory-like Tcf1+ T cells lack a characteristic effector signature they 
share multiple molecular and functional properties with central memory cells. Both express Tcf1, 
IL7Ra, CD62L, Ccr7, Id3 etc and have the potential to efficiently expand in response to antigen 
re-challenge, produce more differentiated progeny and regenerate themselves. These novel 
insights require a significant revision of the concept of T-cell differentiation in chronic infections. 
They highlight that the key principal guiding T-cell differentiation in response to acute infection, 
i.e. the generation of differentiated cells and less differentiated T-cells, which retain proliferative 
potential, is conserved in chronic infections. Thus, the findings provide a mechanistic explanation 
for how effector T-cell responses are maintained long-term and why such responses can select 
epitope-escape variants in late stage HIV infections (Price et al., 2004; Walker and McMichael, 
2012) or control virus load in chronic SIV infections in Rhesus macaques (Jin et al., 1999; 
Schmitz et al., 1999). Along this line we show that Tcf1+ cells have an enhanced potential to 
control virus infection as compared to Tcf1- cells. However, it is unlikely that Tcf1+ cells contribute 
directly to viral control as they lack the hallmarks of effector CD8 T-cells. Rather, they contribute 
to viral control indirectly by sustaining the production of Tcf1- cells, which have limited potential to 
expand but have effector potential. Collectively, the functional properties Tcf1+ cells suggest that 
these cells exert stem cell-like activity to maintain a productive T cell response to chronic 
infection.  
Prior work has identified a sub-compartment of proliferating cells among chronically stimulated 
CD8+ T cells, which expressed intermediate levels of PD-1 (PD-1int), high levels of T-bet but not 
Eomes (Paley et al., 2012). These cells gave rise to non-proliferating PD-1hi T-betlo Eomes+ cells. 
The Tcf1+ T-cells described herein express low levels of cell division related genes and are 
predominantly PD-1hi T-betlo and Eomes+. The difference to (Paley et al., 2012) is likely explained 
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by heterogeneity of the PD-1hi T-betlow population. Together, the findings suggest that the immune 
response to chronic infection comprises several distinct compartments whose precise hierarchical 
order remains to be investigated further. Irrespectively, our data show that Tcf1+ T-cells are 
sufficient to sustain the immune response to chronic infection, indicating that they have a 
privileged position in this hierarchy.  
A key difference to central memory cells is that Tcf1+ T-cells display an exhausted phenotype, 
including the expression of co-inhibitory receptors such as PD-1 and Lag-3. Our data also 
demonstrate that the “exhausted” phenotype is predominantly established prior to terminal cell 
differentiation, at the stage of memory-like T-cells. Nevertheless, we also find inhibitory receptor 
genes, such as 2B4 or Tim3, which are expressed by Tcf1- but not by Tcf1+ T-cells. Together, our 
data show that most of the chronic phenotype is present in memory-like cells but that certain 
parts are acquired during the transition into terminally differentiated Tcf1- cells. The 
compartmentalization of inhibitory receptor expression predicts distinct cellular responses to 
inhibitory receptor blockade. For example Tim3 blockade will preferentially act on the terminally 
differentiated Tcf1- cells. On the other hand PD-1 blockade will act on both Tcf1+ and on Tcf1- 
cells. The former leads to the expansion of the population and production of Tcf1- cells, as shown 
herein and discussed below, and the latter improves the effector capacity of Tcf1- cells, 
consistent with in numerous prior studies (Speiser et al., 2014).  
Blocking inhibitory signals mediated through PD-1/PD-L1 interaction improves immune responses 
to chronic infection and cancer. While it has been shown that this treatment significantly 
increases the number of pathogen-specific T cells, it remained so far unclear how these 
additional cells are generated. It was possible that the blockade somehow induces a certain level 
of proliferation in the entire pathogen-specific population. However, we show that PD-L1 or PD-1 
blockade unleashes the expansion potential of Tcf1+ cells. These insights provide a proof of 
concept that Tcf1+ cells are susceptible to therapeutic interventions. Thus the therapeutic effects 
of PD-1/PD-L1 blockade possibly depend on the restoration of the effector capacity of 
differentiated T cells and the enhanced proliferation and differentiation of Tcf1+ cells. 
Interestingly, inhibitory receptor blockade increased the size of the Tcf1+ compartment itself. With 
 16 
regard to the treatment of cancer patients, these findings raise the possibility that, in addition to 
the presence of a tumor antigen-specific immune response, the presence of Tcf-1+ cells 
represents an additional condition for PD-1 blockade to produce significant therapeutic benefit.  
In conclusion, we have identified a subpopulation of virus-specific CD8+ T-cells during LCMV 
clone-13 infection that sustains the ongoing immune response and mediates memory-like 
function. These cells do not show evidence for effector differentiation, but show multiple 
similarities to central memory CD8+ T-cells together with a so-called “exhausted” or chronic 
phenotype. We therefore propose to refer to these cells as memory-like T-cells associated with 
antigen persistence (TMAP) to provide a specific term for this previously uncharacterized T-cell 
population. The existence of these cells suggests that memory specializes according to the 
particular conditions of T cell stimulation. All together, we are not only identifying a memory T-cell 
equivalent in chronic infection, but also providing proof-of-concept that TMAP represent a target for 
therapeutic interventions against chronic infections and possibly malignant tumors. 
 
 
EXPERIMENTAL PROCEDURES 
Mice 
Mouse strains, which are described in detail in supplemental methods, were bred and maintained 
in the SPF facility and infected in the conventional animal facility of the University of Lausanne. 
Experiments were performed in six-week-old or older mice in compliance with the University of 
Lausanne Institutional regulations and were approved by the veterinarian authorities of the 
Canton de Vaud. 
 
Detailed descriptions of viral infection, in vivo antibody treatment, Purification of mouse T-cells 
and adoptive cell transfers, surface and intracellular staining, antibodies and flow cytometry as 
well as RNA seq analysis are provided in supplemental materials. 
 
Data analyses 
Bar graphs depict the mean ±sem or ±SD as indicated. Statistical analyses were performed using 
Prism 6.0 (Graphpad Software). Paired and non-paired t tests (two-tailed) were used according to 
the type of experiments. P-values ≤ 0.05 were considered significant (*: p<0.05; **: p<0.01; ***: 
p<0.001); p-values >0.05; non-significant (ns).  
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Figure 1: Normal expansion but impaired T-cell maintenance and virus control without 
Tcf1. C57/BL6 (Wt) or Tcf7-/- (KO) mice were infected with 2x106 PFU LCMV clone-13 (c13). The 
fraction of T-cells specific for gp33 and gp276 was determined on day 8 (A) or 56 (B) post 
infection using MHC tetramers. Representative CD8+ gated flow cytometry plots and 
corresponding data graphs are shown. Virus titers were determined at day 9 (C) or day 56 (D) 
post infection in the kidney or at the indicated time points in the blood (E). (F-H) C57/BL6 mice 
(CD45.1+ or CD45.1+CD45.2+) (F, G) or Vb5 transgenic mice (CD45.1+) (H) were engrafted with 
Wt or KO P14 T-cells (CD45.2+) prior to infection with LCMV c13. P14 T-cell numbers were 
determined 8 (F) or 28 (G) days post-infection in the spleen of C57/BL6 mice and or on day 28 in 
Vb5 transgenic mice (H). Each symbol (A-D, F-H) represents data from an individual mouse; 
small horizontal lines indicate the mean. Data are representative of two independent experiments 
with at least three mice per group (A-D, F-H) or combined from two independent experiments (E). 
Error bars=s.e.m.. ***p<0.001; **p<0.01; p<0.05. ns=not significant (p>0.05) based unpaired t-
test. PFU: plaque-forming units. The broken line in E depicts the limit of detection. 
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Figure 2: T-cell differentiation remains unchanged in the absence of Tcf1.  
Vb5 transgenic recipient mice were engrafted with either wild-type (Wt) or Tcf7-/- (KO) P14 T-cells 
and infected with LCMV c13. Splenocytes were analyzed 28 days post infection. PD-1 (A), Lag-3 
(B) or Granzyme B (GzmB) (C) expression of KO (green) or wild-type (blue) P14 T-cells 
compared to host CD8+ T-cells (grey shadow, left) and calculated mean fluorescent intensity data 
(right). (D, E) Splenocytes were re-stimulated in vitro with gp33 peptide, intracellularly stained for 
IFNg and TNF and analyzed by flow cytometry. Shown are representative flow cytometry plots of 
KO or wild-type P14 T-cells (D, left), the fraction of IFNg+ P14 cells that co-produce TNF (D, 
right), and the frequency of P14 T-cells that produce IFNg (E). Each symbol (D, E) represents 
data from an individual mouse; small horizontal lines indicate the mean. Data are representative 
of four independent experiments with at least five mice per group. Error bars (A, B, C), s.e.m. 
*p<0.05; ns=not significant (p>0.05) by unpaired t-test. 
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Figure 3: Tcf1 expression preserves proliferative potential of T cells in chronic infections.  
(A, B) Vb5 mice were engrafted with either Tcf7-/- (KO) or wild-type P14 T-cells and infected with 
LCMV c13. 4 weeks post-infection, P14 T-cells were re-isolated from spleen by flow cytometry-
assisted cell sorting and transferred into naïve secondary Vb5 host followed by an LCMV 
Armstrong (Arm) infection. (B) Population expansion of P14 T-cells in the secondary host 8 days 
after the LCMV Arm challenge relative to the engrafted cells. Engraftment was calculated 
assuming a 10% “take” of transferred cells. (C) C57/BL6 mice were engrafted with either KO or 
wild-type P14 T-cells prior to infection with LCMV c13 or Arm. Splenocytes were harvested at the 
indicated time points post infection and intracellularly stained for Tcf1. Shown are representative 
histograms of P14 T-cells (blue) compared to endogenous host CD8+ T-cells (grey shadow) or as 
a control with KO P14 T-cells (green). Numbers above the gates indicate the percentage of wild-
type P14 T-cells expressing Tcf1. Each symbol (B) represents an individual mouse. Data are 
representative of two (B) or three (C) independent experiments, all with at least four mice per 
group and with similar results. *p<0.05 by unpaired t-test. 
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Figure 4: Only Tcf1 expressing T-cells retain robust proliferative potential in chronic 
infections.  
Vβ5
Arm
Readout
(d8)
GFP    P14 sort & analysis
(d28)
c13GFP+ P14
d-1 d0Vβ5
G H
d0
Figure 4
0 10 20 30
0.0
0.5
1.0
1.5
3.0
3.5
Time after infection (d)
%
 P
14
 o
f C
D8
+ 
ce
lls d8 Tcf7-GFP
+ P14
d8 Tcf7-GFP- P14
I
Tcf7-GFP +-
c13
d-1 d0Vβ5
c13
d0Vβ5
GFP+/- P14 sort
(d8)
d8
Tcf7-GFP+ P14
A BP14CD19+ P14CD19+
102 103 104 105
0
20
40
60
80
100
102 103 104 105
0
20
40
60
80
100
C
102 103 104 105
0
102
103
104
105
8.7
87.8
pre-sort
Tcf7-GFP P14
d28
102 103 104 105
0
102
103
104
105
100
102 103 104 105
0
102
103
104
105
100
 GFP+ P14
GFP- P14
post-sort
102 103 104 105
0
20
40
60
80
100
GFP+ P14
Host CD19+
GFP- P14
D E
Po
pu
lat
ion
ex
pa
ns
ion
 (f
old
)
Tcf7-GFP +-
Tcf7-GFP+ P14
102 103 104 105
0
102
103
104
105 0.4
input:
102 103 104 105
0
102
103
104
105 7.9
Tcf7-GFP- P14
d28+8
0 8
102
103
104
105
Tc
f7
-G
FP
+  P
14
/sp
lee
n
Time after
transfer (d)
F
Tcf1GFP
Tcf1
Tc
f7
-G
FP
CD45.2
GF
P
CD8
d28+8
100
101
102
103 *
103
104
105
106
P1
4/
sp
lee
n
d39
*
+/-
%
 o
f M
ax
%
 o
f M
ax
%
 o
f M
ax
 27 
(A) Validation of naïve Tcf1 P14 reporter mice. Shown is GFP (left) and Tcf1 (right) expression by 
CD19+ B cells and P14 CD8 T-cells. (B) Experimental setup used in C-F. Vb5 mice were 
engrafted with naïve Tcf1-GFP+ P14 T-cells and infected with LCMV c13. Four weeks later, 
splenic P14 T-cells were separated into Tcf1-GFP+ and Tcf1-GFP- cells by flow cytometry-
assisted cell sorting. Tcf1-GFP+ and Tcf1-GFP- P14 cells were separately transferred into 
secondary naïve Vb5 mice, which were then challenged with LCMV Armstrong. (C) P14 T-cells 
before (left) and after (middle) the separation and confirmation that Tcf1-GFP+ but not Tcf1-GFP- 
P14 T-cells express Tcf1. (D) Population expansion (fold) of Tcf1-GFP+ and Tcf1-GFP- P14 T-
cells in the secondary host 8 days after the LCMV Arm challenge. Shown are calculated 
population expansions assuming a 10% “take” of the transferred cells. Lines indicate Tcf1-GFP+ 
and Tcf1-GFP- derived from the same primary host. (E) Representative flow cytometry plots of 
GFP expression of re-expanded Tcf1-GFP+ and Tcf1-GFP- P14 T-cells and (F) absolute number 
of Tcf1-GFP+ cells 8 days after the LCMV Arm challenge. (G) Experimental setup used in H, I. 
Vb5 mice were engrafted with naïve Tcf1-GFP+ P14 T-cells and infected with LCMV c13. Eight 
days post infection, splenic P14 T-cells were separated into Tcf1-GFP+ and Tcf1-GFP- cells by 
flow cytometry-assisted cell sorting and transferred into time-matched LCMV c13 infected Vb5 
mice. (H) Kinetics of appearance of P14 Tcf1-GFP+ and Tcf1-GFP- cells after the transfer. (I) 
Number of P14 cells per spleen (d30) derived from d8 transferred Tcf1-GFP+ (blue) or Tcf1-GFP- 
cells. Each symbol (D, H) represents data from an individual mouse. Data are representative of 
three (A-E) or two (G-I) independent experiments with at least three mice per group and with 
similar results. Statistical analysis ratio paired t-test. 
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Figure 5: Molecular and phenotypic characterization of Tcf1+ cells.  
(A-C) Naive Tcf1-GFP+ P14 T-cells (Naive) were transferred into Vb5 or B6 mice, which were 
infected with LCMV c13 or Arm, respectively. Four weeks later Tcf1-GFP+ and Tcf1-GFP- P14 
cells were flow sorted and subjected to gene expression analysis using RNAseq.  
(A) Principal component analysis (PCA) of normalized gene expression counts in naive P14 cells 
(Naive) (red), Tcf1+ and Tcf1- P14 cells obtained at d28 post LCMV Arm infection (Memory Tcf1+, 
 29 
(purple) and Memory Tcf1- (orange)) or at d28 post LCMV c13 infection (Chronic Tcf1- (green) 
and chronic Tcf1+ (blue). Each dot represents an individual sample. 
(B) PCA of genes differentially expressed between naive cells and the populations described 
above or between naive cells and populations obtained from virus-specific cells at d30 post 
LCMV Arm infection (Memory) (olive) (Memory), at d8 post LCMV Arm or c13 infection (Effector) 
(Black) and at d30 post for c13 infection (Exhausted) (light green) using published microarray 
data (Doering et al., 2012) (GSE41867). PCA was done on Z-scores from the comparisons 
versus naive. PC1 separates the two sets of experiments. PC2 separates the different cell types 
and groups memory populations together and exhausted cells with chronic Tcf1- cells. This 
validates the combination of the two data sets. Tcf1+ cells from chronic infections are clearly 
distinct from all other populations.  
(C-I) Vb5 mice were engrafted with naïve Tcf1-GFP+ or naïve Wt P14 T-cells and infected with 
LCMV c13. 4-5 weeks post-infection, splenocytes were surface and intracellularly stained for the 
indicated markers. Tcf1 positive or negative sub-fractions were distinguished by GFP expression 
or by intracellular Tcf1 staining. (C) Percentage of CD62L+ cells and mean fluorescence intensity 
(MFI) of CD127 expression by Tcf1-GFP+ (blue) or Tcf1-GFP- (green) P14 T-cells compared to 
Vb5 host CD8+ T-cells (grey shadow). (D) Splenocytes were re-stimulated in vitro with gp33-
peptide and stained intracellularly for IFNg and IL-2. Shown is the fraction of IFNg+ cells that 
produce IL-2 by gated Tcf1-GFP+ or Tcf1-GFP- P14 T-cells. (E) Representative flow cytometry 
plots showing co-expression Tcf1 and Eomes (top left) or Tcf1 and T-bet in Wt P14 T-cells (top 
right). Corresponding bar graphs depict the percentage of Eomes+ cells (bottom left) or the MFI of 
T-bet expression (bottom right) by Tcf1- (green) and Tcf1+ P14 cells (blue).  
(F) Gene set enrichment test of an effector gene signature (Doering et al. 2012) over the chronic 
Tcf1+ versus Chronic Tcf1- gene list ranked by the t-statistic. Barcode plots with relative 
enrichment scores for 300 up-regulated genes (red) and 180 down-regulated genes (blue) in the 
effector signature. There is a significant enrichment of the effector signature in chronic Tcf1- but 
not in chronic Tcf1+ cells. 
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(G) MFI of Granzyme B (GzmB) expression (left) and percentage of KLRG1+ cells and (H) MFI of 
PD-1 (left) or Lag-3 (right) by Tcf1-GFP+ (blue) or Tcf1-GFP- (green) P14 T-cells compared to 
Vb5 host CD8+ T-cells (grey shadow). 
(I) Splenocytes were re-stimulated in vitro with gp33-peptide and stained intracellularly for IFNg 
and TNF. Shown are representative flow cytometry plots of Tcf1-GFP+ or Tcf1-GFP- P14 T-cells 
(left), the fraction of Tcf1-GFP+ or Tcf1-GFP- P14 T-cells that produce IFNg (top right) or the 
fraction of IFNg+ Tcf1-GFP+ or Tcf1-GFP- P14 T-cells that co-produce TNF (bottom right). Each 
symbol (I) represents an individual mouse; small horizontal lines indicate the mean. Data are 
representative of 2-4 independent experiments each with at least three mice per group. Error 
bars (D, F- H) s.e.m. Statistical analysis unpaired t-test.  
(K-M) Analysis of Wt and KO P14 reporter T-cells. (K) Tcf1 and Tcf1-GFP expression by Wt (top) 
and KO P14 reporter T-cells (bottom) from naive mice. (L) Tcf1-GFP expression by Wt (top) and 
KO P14 reporter T-cells (bottom) at d8 (left) and d28 post LCMV c13 infection (right). (M) Ly108 
(Slamf6) expression by Wt and KO P14 reporter T-cells at d28 post LCMV c13 infection. Data are 
representative of two independent experiments (one using Vb5 and one using Wt recipients) both 
with 2-3 recipients per group and with similar results. 
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Figure 6: Tcf1+ T-cells with memory characteristics in HCV infection.  
HCV-specific CD8 T-cells were enriched from patients with chronic HCV infection (A, n=7) and 
analyzed for Tcf1 versus CD127 expression in comparison to naive CD8+ T-cells from a healthy 
donor (B, n=6). (c) The fraction of Tcf1+ HCV-specific T-cells was compared to the indicated 
CD8+ T-cell subset in healthy donors. (D) MFI of CD127 expression in Tcf1+ versus Tcf1- HCV-
specific CD8+ T-cells. (E) MFI of PD-1 expression in Tcf1+ HCV-specific CD8+ T-cells (filled dots) 
as compared to naïve CD8+ T-cells from healthy donors (open dots). ***p<0.0001; **p<0.001; 
*p<0.05; ns=not significant (p>0.05) by paired or unpaired t-test. 
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Figure 7: PD-1 induced re-activation of T-cells in chronic infections requires Tcf1+ T cells.  
(A) Experimental setup used in B, C. CD45.2+ Tcf7-/- (KO) and CD45.1+ Wt P14 T-cells were co-
transferred into CD45.1/2+ mice and subsequently infected with LCMV c13. Twenty-three days 
post-infection, mice were treated at 3-day intervals with 200 µg anti-PD-L1 antibody or an isotype 
control. (B) Frequency of KO and Wt P14 T-cells among total cells in the blood after 
administration of anti PD-L1 (left) or istoype control (right). (C) Absolute number of Tcf1+ Wt P14 
T-cells after isotype or anti-PD-L1 treatment. Each symbol represents data from an individual 
mouse; small horizontal lines indicate the mean. Data are representative of two independent 
experiments (one anti-PD-L1 and one anti-PD-1), all with at least four mice per group and with 
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similar results. *p<0.05; ns=not significant (p>0.05) based on unpaired t-test. (D) Experimental 
setup used in E. Vb5 mice were engrafted with naïve Tcf1-GFP+ P14 T-cells and infected with 
LCMV c13. On d15 post infection, splenic P14 T-cells were flow sorted into Tcf1-GFP+ and Tcf1-
GFP- cells and transferred into c13 infection time-matched secondary Vb5 mice. Secondary 
recipients were treated with anti-PD1 or isotype control antibody and analyzed on day 32-35. (E) 
Population expansion (fold) of Tcf1-GFP+ and Tcf1-GFP- P14 T-cells in secondary recipients 
following treatment with anti-PD1 (aPD1) or isotype control Ab. Each symbol represents an 
individual secondary recipient, whereby recipients receiving input cells from one donor are 
connected with a line. Shown is the fold population expansion assuming a 10% “take” of 
transferred cells. Data are compiled from two independent experiments using a total of 8 or more 
mice per group. *p<0.05; ns=not significant (p>0.05) based on unpaired t-test.  
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Supplemental Figure 1 
 
 
 
Figure S1, refers to Figure 1: The reduced abundance of Tcf7-/- P14 cells is not due to rejection by the host. 
(A) Schematic representation of the experiment. Vb5 mice (CD45.1+) were engrafted with Tcf7+/+ wild type (Wt) or 
Tcf7-/- P14 T cells (CD45.2+) prior to infection with LCMV clone-13 (c13). Recipient mice received a secondary graft 
of CFSE-labeled (CFSE+) naive Wt or Tcf7-/- P14 splenocytes (CD45.2+), respectively, >d30 post c13 infection. In 
parallel, CFSE-labeled (CFSE+) naive Wt or Tcf7-/- P14 splenocytes were injected into naive Vb5 mice. The 
abundance of CFSE+ CD8+ CD45.2+ cells was determined one day later.  
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(B) Representative density plots show the presence of host cells (CD45.2- CFSE-), the primary P14 graft (CD45.2+ 
CFSE-) and the secondary P14 graft (CD45.2+ CFSE+) among gated CD8 T cells in the spleen of c13 infected Vb5 
mice. Naive mice did not receive a primary graft and thus lack CD45.2+ CFSE- cells. Numbers depict the percentage 
of cells in the respective gate.  
(C) Number of Wt and Tcf7-/- P14 cells (primary graft) in recipient spleen, confirming a reduced abundance of Tcf7-/- 
P14 cells in c13 infected Vb5 mice. 
(D) Number of CFSE+ Wt P14 cells (secondary graft) (left) and CFSE+ Tcf7-/- P14 cells in the spleen of naive mice or 
c13 infected Vb5 mice. There is no significant difference between naive and mice that previously received Wt or  
Tcf7-/- P14 cells, respectively. The bar graph shows mean ±SD (n=3) from a single experiment. ns; not significant, 
p>0.05 based on unpaired t-test. 
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Supplemental Figure 2 
 
 
 
 
Figure S2, refers to Figure 2: Initial T cell differentiation remains unchanged in the absence of Tcf1.  
C57/BL6 mice (CD45.1+) were engrafted with Tcf7-/- or Tcf7+/+ (wild type, Wt) P14 T cells (CD45.2+) prior to 
infection with LCMV clone-13. (A, B) Splenocytes were re-stimulated with gp33-peptide in vitro, intracellularly 
stained for IFNg and TNF and analyzed by flow cytometry. Shown are representative flow cytometry plots of Wt or 
Tcf7-/- P14 T cells (A, left), the fraction of IFNg positive P14 cells that co-produce TNF (A, right), and the frequency 
of P14 T cells that produce IFNg (B). (C, D) Representative PD-1 (C) and Lag-3 (D) expression histograms of d8 
Tcf7-/- or Wt P14 T cells and total host CD8+ T cells (left) and calculated mean fluorescent intensity (MFI) for all mice 
(right). Each symbol (A, B) represents an individual mouse; small horizontal lines indicate the mean. Data are 
representative of two independent experiments with at least five mice per group. Error bars (C, D), s.e.m. Statistical 
analysis unpaired t-test. 
 
 
  
B
0
20
40
60
80
100
%
 IF
Nγ
+ 
of
to
ta
l P
14
 ce
lls
ns
%
 T
NF
+ 
of
 
IF
Nγ
+ 
P1
4 
ce
lls
ns
0
20
40
60
80
100A
102 103 104 105
102
103
104
105
57
25.5
102 103 104 105
102
103
104
105
58.6
22.3
Wt P14 Tcf7 -/- P14
Wt Tcf7-/-Wt Tcf7-/-
TN
F
IFNγ
C Wt P14
Tcf7 -/- P14
   Host CD8
D nsns
PD
-1
 (M
FI
)
La
g-
3 
(M
FI
)
102 103 104 105
0
20
40
60
80
100
102 103 104 105
0
20
40
60
80
100
Wt P14
Tcf7 -/- P14
  Host CD8
0
500
1000
1500
2000
2500
0
200
400
600
Wt Tcf7-/- WtPD-1 Lag-3 Tcf7-/-
%
 o
f M
ax
%
 o
f M
ax
 37 
Supplemental Figure 3 
 
 
 
 
Figure S3, refers to Figure 3: Tcf1 expression in Wt P14 cells responding to c13 in Vb5 recipients 
Schematic representation of the experiment: Vb5 mice were engrafted with Wt P14 T cells prior to infection with 
LCMV c13. Splenocytes were harvested and intracellularly stained for Tcf1 expression at d8 or d28 post infection. 
Representative histogram overlays showing Tcf1 expression by P14 T cells (blue) compared to endogenous host CD8+ 
T cells (grey fill). Numbers depict the percentage of P14 T cells expressing Tcf1. Data are representative of two 
independent experiments, each with at least three mice per group and with similar results. 
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Supplemental Figure 4 
 
 
 
 
Figure S4, refers to Figure 4: Analyses of polyclonal CD8 T cells responding to c13 using Tcf1 reporter mice 
(A) A bacterial artificial chromosome (BAC) containing the murine Tcf7 locus was modified by inserting EGFP into 
the first translation codon of the Tcf1 open reading frame. In addition, mCherry, was inserted into a downstream 
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translation codon to prevent the expression of a dominant negative Tcf1 isoform. The modified BAC was used to 
generate transgenic mice on a B6 background.  
(B) B6 Tcf7-GFP reporter mice were analyzed for gp276, gp33 and np396 tetramer staining among CD8 T cells at day 
29 of LCMV c13 infection (top). Representative histograms show Tcf7-GFP expression in gated tetramer+ cells (blue) 
as compared to CD44- (naive) CD8 T cells (grey fill). Numbers depict the mean percentage (±SD) of tetramer+ cells 
among total CD8 T cells (top) or of Tcf7-GFP+ cells among gated tetramer+ cells of n=5 mice. 
(C) Schematic outline of the experimental approach. B6 Tcf7-GFP reporter mice were infected with LCMV c13 and 
29 days later Tcf7-GFP+ and Tcf7-GFP- CD8 T cells were analyzed using tetramer or flow sorted and transferred into 
Vb5 mice, which were then infected with LCMV Arm. Eight days later donor-derived CD8 T cells (CD45.2+) were 
analyzed using tetramer. 
(D) Representative histograms show GFP expression among CD8 T cells from the spleen of c13 infected B6 Tcf7-
GFP reporter mice (left) and the analysis of gated Tcf7-GFP+ and Tcf7-GFP- CD8 T cells with gp276 tetramers 
(middle).  After transfer of Tcf7-GFP+ or Tcf7-GFP- CD8 T cells into Vb5 recipients and re-challenge with LCMV 
Arm, gated CD8 T cells present in the spleen were analyzed using tetramers (right). Numbers depict the fraction of 
gp276 tetramer+ cells among total CD8+ T cells present in the spleen.  
(E) The number of gp276 or gp33 tetramer+ cells in the input (d29) and the output splenocyte population (d29+8) was 
used to calculate the fold expansion of tetramer+ cells, assuming 10% take of the transferred population. Symbols 
connected with a line depict Tcf7-GFP- and Tcf7-GFP+ populations derived from the same donor mouse.  
(F) Virus titers were determined at d8 post LCMV Arm infection in the spleen. PFU: plaque-forming units. The 
broken line indicates the limit of detection (L.O.D.). 
(G) Representative flow cytometry plots depicting Tcf7-GFP expression among gp276 tetramer+ cells following 
LCMV Arm challenge (d29+8). Cells derived from Tcf7-GFP- cells are Tcf7-GFP- (top). Cells derived from Tcf7-
GFP+ cells are mostly Tcf7-GFP- but around 5-10% of cells are Tcf7-GFP+ (bottom).  
(H) The number of Tcf7-GFP+ gp276 or gp33 tetramer+ cells at d0 (0) and at d8 (8) post transfer was used to calculate 
the fold expansion of Tcf7-GFP+ cells in the spleen, assuming 10% take of the transferred cells. Cell number at d0 was 
set to 1. The expansion of Tcf7-GFP+ cells was at least 8 fold for gp276 and 17 fold for gp33 tetramer+ cells in all 5 
recipients.  
(D, G, E, H) Equivalent results were obtained for np396 (not shown). Each symbol in E, F, H represents data from an 
individual mouse. Statistics: paired t-test, n= 5. Except F, which is from a single experiment, all data are 
representative of two independent experiments. Small horizontal lines indicate the mean. Statistics: paired t-test with 
n= 5. 
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Supplemental Figure 5 
 
 
 
 
Figure S5, refers to Figure 5: Characterization of Tcf1+ cells from chronic infection 
(A) Numbers of differentially expressed genes of all pairwise comparisons. Blue bars correspond to the total number 
of genes found differentially expressed (FDR 5% and fold-change cutoff 2) for the comparison between the conditions 
indicated by the dots and edges below each bar.  
(B) Gene signature of Chronic Tcf1+ cells. Each gene signature corresponds to the overlap (intersection) of the 
significantly differentially expressed genes (FDR 5%; fold-change >2) when a particular cell population is compared 
to all other counterparts. The heatmap consists of 498 genes displaying a significant differential expression uniquely 
in chronic Tcf1+ cells (391 up-regulated and 107 down-regulated), 502 genes unique to chronic Tcf1- cells (389 up-
regulated and 113 down-regulated) and 216 genes unique to Tcf1+ memory cells (72 up-regulated and 144 down-
regulated). This last signature did not take into account Tcf1- memory cells. 
(C-D) Gene set enrichment tests of memory (Acute d30) (C) and exhaustion (Chronic d30) gene signatures from 
(Doering et al. 2012) over the chronic Tcf1+ versus chronic Tcf1- comparison ranked by the t-statistic. Barcode plots 
indicating relative enrichment scores for 51 up-regulated genes (red) and 14 down-regulated genes (blue) in the 
memory signature (C) and for 83 up-regulated genes (red) and 108 down-regulated genes (blue) in the exhaustion 
signature (D). 
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Supplemental Figure 6 
 
 
 
 
Figure S6, refers to Figure 5: Analysis of selected memory, effector and exhaustion-related features in chronic 
Tcf1+ cells 
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 (A) Expression of selected cell division related genes in naive, Tcf1+ memory, chronic Tcf1- and chronic Tcf1+ P14 
cells.  
(B, C) Analysis of memory characteristics (B) Expression of selected memory related genes in naive, Tcf1+ memory, 
chronic Tcf1- and chronic Tcf1+ P14 cells. (C) Expression of CD62L (gp33 tetramer+) and IL7Ra (CD127) (gp276 
tetramer+) by polyclonal Tcf7-GFP+ (blue) and Tcf7-GFP- cells (green) as compared to naive (CD44-) host CD8 T cells 
present in the spleen at d32 of c13 infection. Bar graphs depict the mean % CD62L+ cells or the MFI of CD127 
staining (±SD) of n=5 and n=8 determinations, respectively.  
(D, E) Analysis of effector-related features. (D) Expression of selected genes involved in effector differentiation or 
function in P14 cells. (E) Expression of KLRG1 by polyclonal gp276 tetramer+ Tcf7-GFP+ and Tcf7-GFP- cells from 
the spleen of c13 infected mice. Bar graph depicts the mean % KLRG1+ cells (±SD) of n=9 determinations. 
(F, G) Analysis of exhaustion-related features. (F) Expression of selected genes associated with exhaustion in the 
indicated population of P14 cells. (G) Expression of PD-1 (gp33 tetramer+) and Lag-3 (gp276 tetramer+) by 
polyclonal Tcf7-GFP+ and Tcf7-GFP- cells from the spleen of c13 infected mice. Bar graphs depict the mean MFIs of 
PD-1 or Lag-3 staining (±SD) of n=10 and n=5 determinations, respectively.  
The bar graphs related to phenotypic analysis are compiled from one (CD62L, Lag-3) or two independent experiments 
(all others). Statistics paired t-test. The bar graphs depicting gene expression analysis show mean relative expression 
(±SD) derived from 3 independent samples. Note that data are shown using a log2 scale and that differences 
mentioned in the text are statistically significant based on one way Anova together with Bonferronis multiple 
comparison test. Statistics is shown for Eomes and Tbx21 (T-bet) whereby ns is not significant. 
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Supplemental Table 4: Patient information 
 
Patient # Gender Age (yr) HCV genotype Viral load IU/ml HLA-A*02 Tetramer 
1 F 62 1a 6079634 NS31406-1415 
2 F 59 1a 297322 NS31073-1081 
3 F 62 1a 680265 NS31406-1415; NS5B2594-2602 
4 M 53 1a 453470 NS31073-1081 
5 M 43 3 167544 NS31073-1081 
6 M 56 3 not determined NS31073-1081 
7 M 30 3 not determined NS31073-1081 
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Supplemental Experimental Procedures 
 
 
Viral infection 
The LCMV 53b Armstrong (Arm) and LCMV clone 13 (c13) strains were propagated in baby hamster kidney cells 
and titrated on Vero African green monkey kidney cells according to an established protocol (Battegay et al., 1991). 
Frozen stocks were diluted in PBS; 2×105 plaque forming units (PFU) of LCMV-Arm were injected intraperitoneally, 
and 2×106 plaque forming units of LCMV c13 were injected intravenously. Blood samples, kidney or spleen 
suspensions from LCMV-infected mice were ‘shock frozen’. Diluted samples were used for infection of Vero cells, 
and viral titers were determined by an LCMV focus-forming assay (Battegay et al., 1991). 
 
In vivo antibody treatment  
Mice were injected intraperitoneally with 200 g of rat anti-mouse PD-L1 (10F.9G2), PD-1 (RMP1-14) or rat IgG2b 
isotype control (LTF-2) every third day starting on d15 or d23 post infection.  
 
Purification of mouse T cells and adoptive cell transfers 
Single cell splenocyte suspensions were obtained by mashing total spleens through a 100 µm nylon cell strainer (BD 
Falcon). Red blood cells were lysed with a hypotonic ACK buffer. CD8+ T-cells were isolated using mouse CD8+ T-
cell enrichment kits (Miltenyi Biotech, Bergisch-Gladbach, Germany or StemCell Technologies). One-2x103 CD45.1+ 
or CD45.2+ naïve congenic Tcf7-/- or Wt P14 T-cells were transferred into naïve CD45.1+ CD45.2+ C57BL/6 mice. A 
tenfold higher number of cells was used in Vb5 hosts. P14 T-cells were enriched from infected mice by staining total 
splenocytes with anti-CD8  (eBioscience, 53-6.7) and CD45.1 (A20) or CD45.2 (clone 104) (both prepared in 
house). CD8+ CD45.1+ or CD8+ CD45.2+ cells were isolated by fluorescence activated cell sorting. The purity of 
sorted cells was greater than 99%. Chronic infection was confirmed by staining grafted cells for PD-1 and/or Lag-3. 
The fold expansion of P14 T-cells in secondary hosts was determined relative to an estimated 10% “take” of 
transferred input cells (Blattman et al., 2002). 
 
Surface and intracellular staining and fluorescent activated cell sorting of mouse cells.  
Surface staining was performed with mAbs for 30 min and with tetramers for 90 min at 4°C in PBS supplemented 
with 2% FCS and 0.01% azide (FACS buffer) using the following antibodies to: CD8a (53-6.7), CD127 (SB/199), 
Lag-3 (eBioC9B7W), KLRG1 (2F1) (all eBioscience); Ly108 (Slamf6) (330-A), PD-1 (RMP1-30) (all Biolegend); 
CD62L (Mel-14) (DOF-UNIL). Tetramers (Db/gp33-41, Db/gp276-286 and Db/NP396-404) were obtained from 
TCMetrix (Lausanne, Switzerland). Anti-CD4 (GK1.5), CD45.1 (A20), and CD45.2 (clone 104) were obtained from 
or custom purified by BioXCell (West Lebanon, NH, USA) and coupled to pacific blue, Alexa647, or FITC using 
labeling reagents from Invitrogen (Zug, Switzerland) or obtained from eBioscience.  
The following antibodies were used for analyzing human HCV-specific CD8+ T cells: (i) anti-CD45RA (HI100), 
F(ab)2 anti-rabbit IgG, anti-Eomes (WD1928), anti-CD127 (eBioRDR5) (all eBioscience); (ii) anti-CD8 (RPA-T8), 
anti-CD14 (M5E2), anti-CD19 (HIB19), anti-CCR7 (150503) (all BD); and (iii) anti-PD-1 (EH12.2H7, BioLegend). 
Viability Dye eFluor 506 (eBiosciences) was used for the exclusion of dead cells. 
Stained cells were analyzed directly or washed twice and fixed in PBS supplemented with 1% formaldehyde, 2% 
glucose and 0.03% azide for 20 min at 4C. Then, cells were washed again and resuspended in FACS buffer.  
For intracellular cytokine staining, splenocytes were re-stimulated in vitro with gp33-41 (gp33) peptide (5 M) for 5h 
in the presence of Brefeldin A (7 µg/ml) for the last 4.5h, fixed and permeabilized (using kits from BD or 
eBiosceince) and stained with mAbs for IFNg (XMG1.2), TNF (MP6-XT22) and IL-2 (JES6-5H4, all from 
eBioscience ) or Granzyme B (GB12, Invitrogen). Transcription factors were detected using the transcription factor 
staining kit from eBioscience and staining with mAbs for Eomes (Dan11mag), T-bet (eBio4B10) (both from 
eBioscience) or Tcf1 (C63D8, Cell Signaling) followed by anti-rabbit IgG PE (eBisocience). 
Flow cytometry measurements of cells were performed on an LSR-II or FACSCanto II flow cytometer (BD). All data 
were analyzed using FlowJo (TreeStar). For cell sorting, living cells were stained in 10% FCS RPMI media and sorted 
on a FACSAria (BD). 
 
Human HCV-specific CD8+ T cells. 
Seven HLA-A*02-positive (HLA-A*02+) subjects with chronic HCV infection (Supplementary Table 4) attending 
the University Hospital of Freiburg were included in the study. Written informed consent was obtained in all cases, 
and the study was conducted in accordance with federal guidelines, local ethics committee regulations, and the 
Declaration of Helsinki (1975). Approval was obtained from the ethics committee of the Albert-Ludwigs-Universität, 
Freiburg, Germany. Peripheral blood mononuclear cells (PBMCs) were isolated from EDTA-anticoagulated blood by 
density gradient centrifugation. Tetramer enrichment procedures were performed as described previously(Nitschke et 
al., 2015). CD8+ T cell subset in healthy donors were defined based on CD45RA, CD28 and CCR7 surface 
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expression: Naïve: CD45RA+CD28+CCR7+; Central memory: CD45RA-CD28+CCR7+; Effector cells: CD45RA-
CD28-CCR7- and CD45RA+ effector memory (EMRA) cells:  CD45RA+CD28-CCR7-). 
 
RNA-seq analysis. 
Sorted GFP+ CD8+ T cells from a naive P14 Tcf7-GFP reporter mouse were used to obtain RNA (“naïve”) or 
adoptively transferred into B6 (CD45.1/2+) or Vb5 (CD45.1+) hosts followed by infection with LCMV Arm or c13, 
respectively. Data are derived from 3 replicate series (2 for Tcf1- memory) each using a distinct donor mouse. At d28 
post infection splenocytes were enriched for CD8 T cells using the EasySep Mouse CD8+ T Cell Isolation Kit 
(StemCell Technologies) and GFP+ and GFP- P14 cells (CD45.2+/1-) were flow sorted. Cells were lysed and stored in 
Trizol before extraction of total cellular RNA using the Direct-zol™ RNA MiniPrep kit (Zymo Research).  
Double stranded cDNA for RNA-seq library preparation was generated using SMART-Seq v4 Ultra Low Input RNA 
reagents (# 634888, Clontech) according to the protocol provided with the reagents beginning with 5 ng of total RNA 
and using 9 cycles of PCR.  150 pg of the resulting cDNA were used for library preparation with the Illumina Nextera 
XT DNA Library reagents (# 15032354, Illumina) using the single cell RNA-seq library preparation protocol 
developed for the Fluidigm C1 (Fluidigm). Cluster generation was performed with the libraries using the Illumina 
TruSeq SR Cluster Kit v4 reagents and sequenced on the Illumina HiSeq 2500 using TruSeq SBS Kit v4 reagents. 
Sequencing data were processed using the Illumina Pipeline Software version 1.82.  
Purity-filtered reads were adapters and quality trimmed with Cutadapt (v. 1.3) (Martin et al., 2011) and filtered for 
low complexity with seq crumbs (v. 0.1.8). Reads were aligned against Mus musculus (version GRCm38) genome 
using STAR (v. 2.4.2a) (Dobin et al., 2013). The number of read counts per gene locus was summarized with htseq-
count (v. 0.6.1) (Anders et al., 2015) using M. musculus (Ensembl v. GRCm38.82) gene annotation. Quality of the 
RNA-seq data alignment was assessed using RSeQC (v. 2.3.7) (Wang et al., 2012). 
Statistical analysis was performed for genes in R (R version 3.1.2). Genes with low counts were filtered out according 
to the rule of 1 count per million (cpm) in at least 1 sample. Library sizes were scaled using TMM normalization 
(EdgeR v 3.8.5) (Robinson et al., 2010) and log-transformed with limma voom function (R version 3.22.4) (Law et 
al., 2014).  PCA analysis was performed on normalized counts. Differential expression was computed with limma 
(Ritchie et al., 2015) by fitting data into a linear model correcting for batch effect. All pairwise comparisons were 
calculated, moderated t-test was used for each contrast and the adjusted p-values were computed by the Benjamini-
Hochberg (BH) method controlling for false discovery rate (FDR) independently.  
Gene signatures for chronic Tcf1+, chronic Tcf1- and Tcf1+ memory cells were independently extracted from the 
pairwise comparisons by taking the intersection of the significantly differentially expressed genes (FDR 5%; absolute 
fold-change (fc) >2) in all comparisons including the cell population for which the signature was computed. For gene 
ontology and KEGG pathway enrichment analysis, we used David (Huang da et al., 2009), using only protein-coding 
genes as a reference list (Huang da et al., 2009). 
Normalized data from published microarray experiments (Doering et al., 2012) was downloaded from GEO database 
(GSE41867). Differential gene expression between effector cells (Acute d8 and Chronic d8), memory cells (Acute 
d30) and exhausted cells (Chronic d30) versus naive cells was computed with limma. In the same way using our 
RNA-seq data, comparisons of Tcf1- memory, Tcf1+ memory, chronic Tcf1- and chronic Tcf1+ cells were compared to 
naive cells. PCA analysis was performed with Z-scores computed from the p-values of these comparisons. 
Gene signatures for effector cells (300 up-regulated and 180 down-regulated genes), exhausted cells (83 up-regulated 
and 108 down-regulated genes) and memory cells (51 up-regulated and 14 down-regulated genes) were generated 
from the (Doering et al., 2012) data based on the comparisons described above, applying FDR 5% and 2-fold-change 
cut-offs. The effector signature includes genes specifically regulated in Acute d8 or Chronic d8 samples. Gene 
signatures consist of gene symbols matching to Ensembl v. GRCm38.82 annotation. Gene set enrichment was tested 
using camera (Wu and Smyth, 2012) against the ranked lists of moderated t-statistics from the comparison of Chronic 
Tcf1+ versus Chronic Tcf1- cells. 
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